Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gene Variation Analysis of Gut Bacteria Reveals Remarkable Stability

By LabMedica International staff writers
Posted on 19 Dec 2012
Data obtained by analyzing the genetic variation within the microbiome from the guts of more than 200 individuals revealed that each person contains a distinct microbiome gene profile and that this profile is remarkably stable.

Investigators at Washington University School of Medicine (St. More...
Louis, MO, USA) and the European Molecular Biology Laboratory (Heidelberg, Germany) developed a framework for metagenomic variation analysis and applied it to 252 fecal metagenomes of 207 individuals from Europe and North America.

They reported in the December 5, 2012, online edition of the journal Nature that by using 7.4 billion reads aligned to 101 reference species, they detected 10.3 million single nucleotide polymorphisms (SNPs), 107,991 short insertions/deletions, and 1,051 structural variants. Subjects sampled at varying time intervals exhibited individuality and temporal stability of SNP variation patterns, despite considerable composition changes in the population of microorganisms in their digestive tracts.

“The microbial DNA in the intestine is remarkably stable, like a fingerprint,” said contributing author Dr. George Weinstock, professor of genetics and molecular microbiology at Washington University School of Medicine. “Even after a year, we could still distinguish individuals by the genetic signature of their microbial DNA.”

“Surprisingly, each of us can be identified by the collective DNA of our gut microbes,” said Dr. George Weinstock. “That collection is individualized, completely analogous to our human genome. Differences in the way individuals respond to various drugs or the way they use specific nutrients can be traced to the genetic variation in our microbial genes as well as in our human genes.”

The finding that each individual has a unique metagenomic genotype may be exploited in the future for the development of personalized diets or drug regimens.

Related Links:
Washington University School of Medicine
European Molecular Biology Laboratory


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automatic CLIA Analyzer
Shine i6000
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.